Adrian Parton Ph.D Overview

  • Primary Position
  • Chairman

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 2

  • Med. Deal Size

  • Med. Valuation

Adrian Parton Ph.D General Information

Biography

Dr. Adrian Parton serves as Chairman at Glyconics. He served as a Partner at Boundary Capital Partners. He has been in the industry for the last 25 years and has successfully grown businesses from concept to production and subsequently into multi-national businesses in the areas of water diagnostics (Genera Technologies Ltd - sold in 2000 to Idexx Labs Inc for $17m), food diagnostics (Matrix MicroScience Ltd - sold to Life Technologies Inc for $20m) and "e-banking" using software and hardware (Cronto - sold to Vasco Data Security in 2013 for €17m). He is currently a Director of; Objective Imaging Ltd (Hardware Software Automation business), DenovoPartners Ltd (provides strategic support for growing businesses), Snapa Ltd (novel packing solutions), and Chairman of Ivy House Country House Hotel. He served as a Board Member at Toxibact. He served as a Board Member at AB-Polyblok.

Contact Information

Primary Position
Chairman, Glyconics
Gender
Male
Address
  • Trafalgar House, Meridian Business Park
  • Norfolk
  • Norwich NR7 0TA
  • England, United Kingdom

Adrian Parton Ph.D Board Seats (2)

Company Industry Ownership Status Financing Status Location Since
Glyconics Diagnostic Equipment Privately Held (backing) Venture Capital-Backed Norwich, United Kingdom
Natrox Therapeutic Devices Privately Held (backing) Venture Capital-Backed Cambridge, United Kingdom

Adrian Parton Ph.D Lead Partner on Deals (3)

Adrian Parton Ph.D has been the lead partner on 3 deals. Their latest deal was with Glyconics, a diagnostic equipment company. The deal was made for on 04-Nov-2021.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Glyconics 04-Nov-2021 Later Stage VC Completed Diagnostic Equipment Norwich, United Kingdom
Glyconics 02-Feb-2021 Completed Diagnostic Equipment Norwich, United Kingdom
AB-Polyblok 30-Mar-2017 Completed Drug Discovery Luton, United Kingdom

Adrian Parton Ph.D Network (28)

Board Members (21)

Name Company Representing Location From
Trevor Stanley Natrox Natrox Cambridge, United Kingdom
Mike Clark Natrox Self Cambridge, United Kingdom
Natrox Natrox Cambridge, United Kingdom
Natrox Praetura Ventures Cambridge, United Kingdom
Glyconics Deepbridge Capital Norwich, United Kingdom

Portfolio Executives (7)

Name Company Role Deal date Location
Paul Jesson Glyconics Financial Director 04-Nov-2021 Norwich, United Kingdom
Berwyn Clarke Ph.D Glyconics Executive Chairman 04-Nov-2021 Norwich, United Kingdom
Glyconics Chief Scientific Officer & Co-Founder 04-Nov-2021 Norwich, United Kingdom
Glyconics Finance Director 04-Nov-2021 Norwich, United Kingdom
Glyconics Chief Technology Officer 04-Nov-2021 Norwich, United Kingdom

Adrian Parton Ph.D Affiliated Funds (1)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Impact Life Fund Boundary Capital Partners Venture - General Closed 2020

Adrian Parton Ph.D FAQs

  • Who is Adrian Parton Ph.D?

    Dr. Adrian Parton serves as Chairman at Glyconics.

  • How much does Adrian Parton Ph.D typically invest?

    Adrian Parton Ph.D's median deal size is .

  • What is Adrian Parton Ph.D’s main position?

    Adrian Parton Ph.D’s primary position is Chairman.

  • How many active board seats does Adrian Parton Ph.D hold?

    Adrian Parton Ph.D holds 2 board seats including Glyconics and Natrox.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »